From Casetext: Smarter Legal Research

Morris & Dickson Co. v. GlaxoSmithKline LLC

United States District Court, E.D. Pennsylvania
May 30, 2023
Civil Action 23-480 (E.D. Pa. May. 30, 2023)

Opinion

Civil Action 23-480

05-30-2023

MORRIS & DICKSON CO., LLC, Plaintiff, v. GLAXOSMITHKLINE LLC, formerly known as “SMITHKLINE BEECHAM CORPORATION,” and doing business as “GLAXOSMITHKLINE,” TEVA PHARMACEUTICAL INDUSTRIES LTD., and TEVA PHARMACEUTICALS USA, INC., Defendants.


ORDER

Hon. Kelley B. Hodge, J.

AND NOW, this 30th day of May, 2023, upon consideration of Defendants' joint Motion to Transfer (ECF Nos. 12 & 26) and any response and opposition thereto, it hereby ORDERED that the Motion to Transfer is GRANTED. Consistent with this Order, the Clerk of Court is directed to TRANSFER this matter to the United States District Court for the District of New Jersey. It is further ORDERED that upon consideration of Defendants' joint Motion to Stay (ECF Nos. 14 & 26) and any response and opposition thereto, the Motion to Stay is DENIED as moot.


Summaries of

Morris & Dickson Co. v. GlaxoSmithKline LLC

United States District Court, E.D. Pennsylvania
May 30, 2023
Civil Action 23-480 (E.D. Pa. May. 30, 2023)
Case details for

Morris & Dickson Co. v. GlaxoSmithKline LLC

Case Details

Full title:MORRIS & DICKSON CO., LLC, Plaintiff, v. GLAXOSMITHKLINE LLC, formerly…

Court:United States District Court, E.D. Pennsylvania

Date published: May 30, 2023

Citations

Civil Action 23-480 (E.D. Pa. May. 30, 2023)